Clarivate Plc (NYSE:CLVT) Given Average Recommendation of “Hold” by Analysts

Clarivate Plc (NYSE:CLVT) has earned an average rating of “Hold” from the eight ratings firms that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $7.75.

Several equities research analysts have recently issued reports on the stock. Barclays dropped their price objective on shares of Clarivate from $6.00 to $5.00 and set an “underweight” rating for the company in a research report on Wednesday, August 7th. Royal Bank of Canada lowered their price target on Clarivate from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Wednesday, August 7th.

Insider Buying and Selling

In other Clarivate news, Director Saurabh Saha sold 17,646 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the transaction, the director now directly owns 23,741 shares of the company’s stock, valued at approximately $160,251.75. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Saurabh Saha sold 17,646 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $6.75, for a total transaction of $119,110.50. Following the completion of the transaction, the director now directly owns 23,741 shares in the company, valued at approximately $160,251.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Andrew Miles Snyder purchased 28,938 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were bought at an average cost of $5.49 per share, with a total value of $158,869.62. Following the transaction, the director now directly owns 288,334 shares of the company’s stock, valued at approximately $1,582,953.66. The disclosure for this purchase can be found here. 22.77% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Clarivate

A number of hedge funds have recently bought and sold shares of CLVT. Exor N.V. lifted its holdings in Clarivate by 2.4% during the 1st quarter. Exor N.V. now owns 67,294,884 shares of the company’s stock worth $500,001,000 after buying an additional 1,566,519 shares during the last quarter. Baupost Group LLC MA raised its position in shares of Clarivate by 27.2% during the 2nd quarter. Baupost Group LLC MA now owns 38,929,635 shares of the company’s stock valued at $221,510,000 after acquiring an additional 8,331,233 shares in the last quarter. Impactive Capital LP lifted its stake in Clarivate by 0.3% during the first quarter. Impactive Capital LP now owns 37,887,185 shares of the company’s stock worth $281,502,000 after purchasing an additional 109,247 shares during the last quarter. Glenview Capital Management LLC boosted its holdings in Clarivate by 22.2% in the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock worth $228,269,000 after purchasing an additional 4,472,302 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Clarivate by 19.5% during the second quarter. Dimensional Fund Advisors LP now owns 14,752,994 shares of the company’s stock worth $83,945,000 after purchasing an additional 2,409,470 shares during the period. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Clarivate Price Performance

CLVT stock opened at $6.94 on Friday. The company has a market cap of $4.64 billion, a PE ratio of -4.18, a price-to-earnings-growth ratio of 3.24 and a beta of 1.17. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 0.83. The stock has a 50-day moving average price of $6.47 and a two-hundred day moving average price of $6.45. Clarivate has a 12-month low of $4.97 and a 12-month high of $9.60.

Clarivate (NYSE:CLVT) last posted its earnings results on Tuesday, August 6th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. Clarivate had a negative net margin of 46.53% and a positive return on equity of 10.01%. The firm had revenue of $650.30 million during the quarter, compared to the consensus estimate of $651.94 million. During the same quarter in the prior year, the company earned $0.16 EPS. The company’s revenue was down 2.8% on a year-over-year basis. As a group, research analysts predict that Clarivate will post 0.64 EPS for the current year.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.